Connect with us


Large Volume Parenteral Market: Growth, Trends, Revenue & Size 2022-27



Large Volume Parenteral Market

Market Overview 2022-2027:

The latest research study “Large Volume Parenteral Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds the global large volume parenteral (LVP) market reached a value of US$ 8.58 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 12.9 Billion by 2027, exhibiting a CAGR of 6.50% during 2022-2027.

Industry Definition and Application:

A large volume parenteral (LVP) refers to the single-dose injection packaged in a glass bottle or a flexible container of more than 100ml capacity after sterilization via heat. It is injected through the skin or other external boundary tissue to directly administrate the active drug substances into the blood vessels, tissues, lesions, etc. A large volume parenteral generally consists of a water-miscible or non-aqueous vehicle, active ingredient, and added substances, such as antioxidants, buffers, preservatives, surfactants, antimicrobial agents, tonicity adjusters, etc. Some of the commonly available LVPs include irrigating solutions, peritoneal dialysis, blood derivatives, drug premixes, contrast agents, etc.

Request a PDF Sample Copy for more detailed market insights:

Market Trends:

The widespread product adoption in administering essential nutrients to patients undergoing treatment for gastrointestinal (GI) diseases, esophageal obstruction, cancer, ulcer, etc., is primarily driving the large volume parenteral market. Additionally, the growing prevalence of non-communicable diseases, such as hypertension, diabetes, obesity, and other metabolic disorders is augmenting the demand for LVPs that are a mixture of dextrose, amino acids, lipids, added electrolytes, trace metals, vitamins, etc. This, in turn, is further catalyzing the market growth.

Besides this, the rising utilization of large volume parenteral in heart surgery for preventing ischemic injury to the myocardium during reperfusion and the blood flow supply restriction is acting as another significant growth-inducing factor. Moreover, the inflating need for fast, safe, and effective methods of drug administration among individuals enduring surgical interventions is anticipated to fuel the large volume parenteral market over the forecasted period.

Large Volume Parenteral Market Report Scope
Report Coverage Details
Market size value in 2021 US$ 8.58 Billion
Market forecast in 2027 US$ 12.9 Billion
Growth Rate CAGR of 6.50% from 2022 to 2027
Base year for estimation 2021
Historical data 2016-2021
Forecast period 2022-2027
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Type, Volume, Application, End Users and Region

Report Segmentation:

The report has been segmented the market into following categories:

Breakup by Type:

  • Soft Bag LVP
  • Plastic Bottle LVP
  • Glass Bottle LVP

Breakup by Volume:

  • 100 ML – 250 ML
  • 250 ML – 500 ML
  • 500 ML – 1000 ML
  • 1000 ML – 2000 ML
  • 2000 ML and More

Breakup by Application:

  • Therapeutic Injections
  • Fluid Balance Injections
  • Nutritious Injections

Breakup by End Users:

  • Hospitals
  • Clinics
  • Others

Breakup by Geography:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape with Key Player:

  • Albert David Ltd.
  • B. Braun Melsungen AG
  • Pharmaceutical Solutions Industry Ltd.
  • Sichuan Kelun Pharmaceutical Co. Ltd.
  • Baxter International Inc.
  • BML Parenteral Drugs
  • Fresenius Kabi AG
  • Grifols S.A
  • Otsuka Pharmaceutical Co. Ltd
  • Thermo Fisher Scientific Inc.

Click here to view detailed information with table of content:

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800